Authors/Years | Number | Oxford Knee | Follow up | Survivorship | Results |
Edmondson et al. [2015] | 364 | Phase 3 | 10 Years | 95% | Better clinical functions and survival at 10 years. |
Yoshida et al. [2013] | 1279 | Phase 3 | 10 Years | 95% | Clinical outcomes are better with 10 years follow up |
Faour et al. [2013] | 511 | Phase 3 | 10 Years | 96% | Clinical outcomes are better than standard open approach. |
Murray et al. [1998] | 143 | Phase 1 & 2 | 8 Years | 97% | Excellent clinical outcomes in the midterm follow up. |
Robertsson et al. [1995] | 663 | Phase 1, 2 & 3 | 20 Years | 92% | Better functional outcomes and few revision to TKA |
Goodfellow & O’Connor et al. [1988] | 103 | Phase 1 & 2 | 10 Years | 98% | Excellent functional satisfaction in the survival rate. |